Home
Home

myelodysplastic syndrome

Can This Celgene Drug Defy the Patent Cliff?

Can This Celgene Drug Defy the Patent Cliff?
Motley Fool

Still Revving Up With Revlimid

Still Revving Up With Revlimid
Motley Fool

What Is So Exciting About MEI Pharma?

What Is So Exciting About MEI Pharma?
Seeking Alpha

Cyclacel Heats Up On Clinical Trial Progression

Cyclacel Heats Up On Clinical Trial Progression
Seeking Alpha

BioMarin Starts Study on BMN673

BioMarin Starts Study on BMN673
Yahoo/Zacks

News

Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
Yahoo/GlobeNewsWire
»